Survival after myocardial infarction according to left ventricular function and heart failure symptoms

IF 3.7 2区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS ESC Heart Failure Pub Date : 2025-03-18 DOI:10.1002/ehf2.15265
Jarle Jortveit, Peder L. Myhre, Kristian Berge, Sigrun Halvorsen
{"title":"Survival after myocardial infarction according to left ventricular function and heart failure symptoms","authors":"Jarle Jortveit,&nbsp;Peder L. Myhre,&nbsp;Kristian Berge,&nbsp;Sigrun Halvorsen","doi":"10.1002/ehf2.15265","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Aims</h3>\n \n <p>Left ventricular (LV) dysfunction following acute myocardial infarction (AMI) is common even in the absence of signs and symptoms of heart failure (HF). Recent trials of patients with LV dysfunction post-AMI have demonstrated low event rates during follow-up. We aimed to assess the real-world prevalence and outcomes post-AMI, stratified by LV ejection fraction (LVEF) and the presence or absence of HF symptoms.</p>\n </section>\n \n <section>\n \n <h3> Methods and results</h3>\n \n <p>Cohort study of patients with AMI registered in the Norwegian Myocardial Infarction Registry 2013–2022. Outcomes were short- and long-term all-cause mortality. Mortality was assessed by Kaplan–Meier survival curves, Life Table and multivariable Cox regression models.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Among 70 809 AMI patients (mean age 68.1 ± 12.9 years, 31% female), preserved (≥50%), mildly reduced (41%–49%) and reduced (≤40%) LVEF were present in 63.5%, 23.2% and 13.3%, respectively. Symptomatic HF was present in 3.3%, 28.1% and 63.2% of patients with preserved, mildly reduced and reduced LVEF. For each LVEF category, 1-year cumulative mortality rate from discharge was 3.9%, 7.8% and 17.8% for asymptomatic, and 16.2%, 13.7% and 20.2% for symptomatic patients, respectively. Symptomatic patients discharged alive had higher risk of mortality than asymptomatic: adjusted hazard ratio 1.85 (1.70–2.02) for preserved LVEF, 1.33 (1.25–1.41) for mildly reduced LVEF and 1.15 (1.06–1.24) for reduced LVEF.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>Reduced LVEF in the acute phase of AMI was associated with up to 20% 1-year mortality after discharge, substantially higher than in recent post-MI trials. Symptoms of HF during the index hospitalization were associated with worse outcomes in patients with preserved LVEF but contributed little additive risk for patients with reduced LVEF.</p>\n </section>\n </div>","PeriodicalId":11864,"journal":{"name":"ESC Heart Failure","volume":"12 4","pages":"2528-2539"},"PeriodicalIF":3.7000,"publicationDate":"2025-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ehf2.15265","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ESC Heart Failure","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/ehf2.15265","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Aims

Left ventricular (LV) dysfunction following acute myocardial infarction (AMI) is common even in the absence of signs and symptoms of heart failure (HF). Recent trials of patients with LV dysfunction post-AMI have demonstrated low event rates during follow-up. We aimed to assess the real-world prevalence and outcomes post-AMI, stratified by LV ejection fraction (LVEF) and the presence or absence of HF symptoms.

Methods and results

Cohort study of patients with AMI registered in the Norwegian Myocardial Infarction Registry 2013–2022. Outcomes were short- and long-term all-cause mortality. Mortality was assessed by Kaplan–Meier survival curves, Life Table and multivariable Cox regression models.

Results

Among 70 809 AMI patients (mean age 68.1 ± 12.9 years, 31% female), preserved (≥50%), mildly reduced (41%–49%) and reduced (≤40%) LVEF were present in 63.5%, 23.2% and 13.3%, respectively. Symptomatic HF was present in 3.3%, 28.1% and 63.2% of patients with preserved, mildly reduced and reduced LVEF. For each LVEF category, 1-year cumulative mortality rate from discharge was 3.9%, 7.8% and 17.8% for asymptomatic, and 16.2%, 13.7% and 20.2% for symptomatic patients, respectively. Symptomatic patients discharged alive had higher risk of mortality than asymptomatic: adjusted hazard ratio 1.85 (1.70–2.02) for preserved LVEF, 1.33 (1.25–1.41) for mildly reduced LVEF and 1.15 (1.06–1.24) for reduced LVEF.

Conclusions

Reduced LVEF in the acute phase of AMI was associated with up to 20% 1-year mortality after discharge, substantially higher than in recent post-MI trials. Symptoms of HF during the index hospitalization were associated with worse outcomes in patients with preserved LVEF but contributed little additive risk for patients with reduced LVEF.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
根据左心室功能和心力衰竭症状确定心肌梗死后的存活率。
目的:急性心肌梗死(AMI)后左室(LV)功能障碍是常见的,即使没有心衰(HF)的体征和症状。最近对ami后左室功能障碍患者的试验表明,随访期间的事件发生率较低。我们以左室射血分数(LVEF)和是否存在HF症状为分层标准,旨在评估ami后的真实世界患病率和结果。方法和结果:对2013-2022年挪威心肌梗死登记处登记的AMI患者进行队列研究。结果是短期和长期全因死亡率。采用Kaplan-Meier生存曲线、生命表和多变量Cox回归模型评估死亡率。结果:70809例AMI患者(平均年龄68.1±12.9岁,女性占31%)中,LVEF保存(≥50%)、轻度减少(41% ~ 49%)和减少(≤40%)分别占63.5%、23.2%和13.3%。保留LVEF、轻度降低LVEF和降低LVEF的患者分别有3.3%、28.1%和63.2%出现症状性HF。对于LVEF各类别,无症状患者1年累计出院死亡率分别为3.9%、7.8%和17.8%,有症状患者1年累计出院死亡率分别为16.2%、13.7%和20.2%。有症状患者存活出院的死亡风险高于无症状患者:保留LVEF的校正风险比为1.85(1.70-2.02),轻度LVEF降低的校正风险比为1.33 (1.25-1.41),LVEF降低的校正风险比为1.15(1.06-1.24)。结论:AMI急性期LVEF降低与出院后1年死亡率高达20%相关,大大高于最近的心肌梗死后试验。指数住院期间HF症状与LVEF保留患者的预后较差相关,但对LVEF减少患者的附加风险影响很小。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
ESC Heart Failure
ESC Heart Failure Medicine-Cardiology and Cardiovascular Medicine
CiteScore
7.00
自引率
7.90%
发文量
461
审稿时长
12 weeks
期刊介绍: ESC Heart Failure is the open access journal of the Heart Failure Association of the European Society of Cardiology dedicated to the advancement of knowledge in the field of heart failure. The journal aims to improve the understanding, prevention, investigation and treatment of heart failure. Molecular and cellular biology, pathology, physiology, electrophysiology, pharmacology, as well as the clinical, social and population sciences all form part of the discipline that is heart failure. Accordingly, submission of manuscripts on basic, translational, clinical and population sciences is invited. Original contributions on nursing, care of the elderly, primary care, health economics and other specialist fields related to heart failure are also welcome, as are case reports that highlight interesting aspects of heart failure care and treatment.
期刊最新文献
Endothelial and inflammatory responses during ex vivo normothermic perfusion of human cardiac grafts. Worsening Heart Failure-Based Hierarchical Endpoints Beyond HF Hospitalization. Expert opinion paper. Glucagon-Like Peptide-1 Receptor Agonists in Patients with Heart Failure with Reduced Ejection Fraction. Metrics of Left Ventricular Active Relaxation Reflect Proteomic Myocardial Remodelling and Reverse Remodelling. Prognosis of Tricuspid Regurgitation after Mitral Transcatheter Edge-to-Edge Repair: The EXPANDed Studies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1